Mirum Pharmaceuticals, Inc. Common Stock MIRM
$98.22
-2.38%
at last close
Financials (TTM)
- Revenue
- $618.07 million
- Net Income
- $-860,207,000
- Net Margin
- -139.18%
- Return on Equity
- 8253.76%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- -626.83
- Price / Sales
- 10.57
Over the trailing twelve months, Mirum Pharmaceuticals, Inc. Common Stock generated revenue of $618.07 million and net income of $-860,207,000, a net margin of -139.18%.
At the last closing price of $98.22, MIRM trades at 10.57 times sales, with a market capitalization of $6.53 billion.
Key Stats
- Last Close
- $98.22
- Market Cap
- $6.53 billion
- 52-Week Range
- $57.79 – $130.00
- Average Volume
- 627K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.